Ignacio Herraiz
Overview
Explore the profile of Ignacio Herraiz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
748
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Herraiz I, Meler E, Mazarico E, Bonacina E, Blanco J, Villalain C, et al.
BMJ Open
. 2024 Sep;
14(9):e089628.
PMID: 39349375
Introduction: Fetal growth restriction (FGR) affects about 3%-5% of term pregnancies. If prenatally detected and anterograde umbilical artery flow is preserved (stage I), it is recommended to deliver at term...
2.
Allotey J, Archer L, Coomar D, Snell K, Smuk M, Oakey L, et al.
Health Technol Assess
. 2024 Sep;
28(47):1-119.
PMID: 39252507
Background: Fetal growth restriction is associated with perinatal morbidity and mortality. Early identification of women having at-risk fetuses can reduce perinatal adverse outcomes. Objectives: To assess the predictive performance of...
3.
Allotey J, Archer L, Snell K, Coomar D, Masse J, Sletner L, et al.
BMJ Med
. 2024 Aug;
3(1):e000784.
PMID: 39184566
Objective: To predict birth weight at various potential gestational ages of delivery based on data routinely available at the first antenatal visit. Design: Individual participant data meta-analysis. Data Sources: Individual...
4.
Carrasco Colom J, Manzanares A, Alvaro Gomez A, Serrano Escribano I, Esquivel E, Perez-Rivilla A, et al.
Eur J Pediatr
. 2023 Aug;
182(10):4647-4654.
PMID: 37561198
Conclusion: In this cohort, the majority of infants born to mothers with COVID-19 during pregnancy were healthy infants with a normal cUS, no hearing loss, and normal neurodevelopment in the...
5.
Gomez-Arriaga P, Nunez N, Zamora B, Villalain C, Risco B, Liebana C, et al.
J Matern Fetal Neonatal Med
. 2023 May;
36(1):2214836.
PMID: 37217456
Introduction: Prenatal diagnosis and counseling of isolated ventriculomegaly (VM) represent a considerable challenge. We aimed to analyze the intrauterine evolution, associated anomalies, and neurodevelopmental outcome using the Battelle Development Inventory...
6.
Villalain C, Gomez-Montes E, Felipe E, Escribano D, Garcia-Torres E, Granados M, et al.
Fetal Diagn Ther
. 2022 Dec;
49(11-12):459-467.
PMID: 36574759
Introduction: Common arterial trunk (CAT) is a congenital heart disease with significant perinatal mortality in which diagnostic agreement remains low. Methods: We conducted a retrospective cohort study on fetuses with...
7.
Villalain C, Herraiz I, Dominguez-Del Olmo P, Angulo P, Ayala J, Galindo A
Front Cardiovasc Med
. 2022 Jul;
9:910701.
PMID: 35845049
Background: Early onset preeclampsia (eoPE) is a hypertensive disorder of pregnancy with endothelial dysfunction manifested before 34 weeks where expectant management is usually attempted. However, the timing of hospitalization, corticosteroids,...
8.
Villalain C, Gomez-Arriaga P, Simon E, Galindo A, Herraiz I
Pregnancy Hypertens
. 2022 Apr;
28:139-145.
PMID: 35381472
Objectives: To evaluate the association between the increment of the sFlt-1/PlGF ratio within the first 72 h after the diagnosis of early-onset preeclampsia (PE) and the time-to-delivery. Secondarily we aimed...
9.
Saviron-Cornudella R, Herraiz I
Gynecol Endocrinol
. 2022 Feb;
38(3):191-192.
PMID: 35225128
No abstract available.
10.
Navajas R, Ramos-Fernandez A, Herraiz I, Galindo A, Bartha J, Corrales F, et al.
Clin Proteomics
. 2022 Feb;
19(1):5.
PMID: 35144530
Background: The high incidence of pre-eclampsia, which affects 2-7% of all pregnancies, remains a major health concern. Detection of pre-eclampsia before the appearance of clinical symptoms is essential to allow...